nan
Artificial Intelligence (AI) In Pharmacovigilance Market Forecast Highlighting Growth From $1.78 Billion To $2.22 Billion
The market for mobile cancer screening devices has experienced rapid expansion in recent years. This market is projected to expand from $4.88 billion in 2025 to $5.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.5%. This historical growth can be linked to several factors, including the increasing prevalence of cancer worldwide, a rise in government-led cancer awareness campaigns, a growing need for programs focused on early diagnosis, broader access to healthcare in underserved areas, and increased investment in healthcare infrastructure.
The mobile cancer screening devices market size is projected to experience substantial expansion in the coming years. This market is set to reach $9.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This anticipated growth during the forecast period is driven by factors such as increasing investment in portable diagnostic technologies, the rising integration of AI-based screening platforms, a growing need for decentralized healthcare services, the broadening scope of preventive healthcare programs, and the continuous development of advanced molecular diagnostic solutions. Key trends influencing the forecast period encompass the increasing uptake of portable cancer screening options, a heightened demand for early cancer detection technologies, the expanded implementation of community-based screening initiatives, a greater emphasis on point-of-care diagnostic capabilities, and the growing utilization of remote healthcare screening services.
Download A Free Sample Report For Comprehensive Market Insights:
Mobile Cancer Screening Devices Market Demand Drivers: What Is Fueling Industry Growth?
The rising occurrence of cancer is projected to fuel the expansion of the mobile cancer screening devices market moving ahead. Cancer incidence is defined as the count of new cancer diagnoses within a defined population over a particular timeframe. This increase in cancer incidence stems from an aging demographic, as advanced age contributes to the buildup of genetic mutations and a reduction in the body’s cellular repair mechanisms, thereby elevating cancer risk progressively. Mobile cancer screening devices facilitate early detection by providing accessible, immediate diagnoses, which in turn enhances the promptness of treatment and substantially improves patient prognoses. As an illustration, in January 2026, data from the Centers for Disease Control and Prevention, a US-based government agency in the United States, indicated that 1,851,238 new cancer cases were documented in 2022, and cancer-related fatalities reached 613,349 in 2023. Consequently, the growing frequency of cancer cases is stimulating the growth of the mobile cancer screening devices market.
Artificial Intelligence (AI) In Pharmacovigilance Market Segmentation: How Is The Market Structured Across Key Categories?
The mobile cancer screening devices market covered in this report is segmented –
1) By Device Type: Imaging Devices; Diagnostic And Detection Devices; Endoscopy Devices; Biopsy Devices
2) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Cervical Cancer; Prostate Cancer; Skin Cancer
3) By Technology: Ultrasound Technology; Computed Tomography Technology; Magnetic Resonance Imaging Technology; Molecular Diagnostics Technology; Artificial Intelligence Based Screening Technology
4) By End User: Hospitals; Diagnostic Centers; Mobile Screening Clinics; Ambulatory Care Centers; Community Healthcare Programs
Subsegments:
1) By Imaging Devices: Portable Mammography Systems; Mobile Computed Tomography Scanners; Portable Magnetic Resonance Imaging Systems; Handheld Ultrasound Devices; Mobile Positron Emission Tomography Systems
2) By Diagnostic And Detection Devices: Liquid Biopsy Devices; Molecular Diagnostic Devices; Biomarker Detection Devices; Point Of Care Diagnostic Analyzers; Cancer Screening Test Kits
3) By Endoscopy Devices: Portable Gastrointestinal Endoscopy Devices; Mobile Bronchoscopy Systems; Capsule Endoscopy Devices; Flexible Endoscopy Systems; Wireless Endoscopy Devices
4) By Biopsy Devices: Needle Biopsy Devices; Vacuum Assisted Biopsy Devices; Image Guided Biopsy Systems; Core Needle Biopsy Devices; Fine Needle Aspiration Devices
Ai-Powered Portable Screening Innovation Advancing Early Lung Cancer Detection
Major companies operating in the mobile cancer screening devices market are focusing on developing innovative solutions, such as AI-enabled mobile diagnostic screening units to enable early and accurate cancer detection, improve diagnostic access in remote areas, and enhance overall screening efficiency. AI-enabled mobile diagnostic screening units are portable healthcare systems equipped with artificial intelligence tools that analyze medical data on the spot to enable fast, accurate, and early disease screening in remote or underserved areas. For instance, in February 2026, Kamala Nehru Memorial Hospital, a India-based not-for-profit, multi-specialty institution, in collaboration with Lenek Technologies, a India-based health-tech startup, launched a project to develop a portable AI-enabled device for early lung cancer detection. The initiative aims to integrate artificial intelligence with clinical diagnostics to improve the speed and accuracy of lung cancer screening, particularly in early-stage cases. This portable solution is also designed to expand access to advanced diagnostic capabilities in remote and resource-limited healthcare settings.
Mobile Cancer Screening Devices Market Major Participants And Competitive Dynamics
Major companies operating in the mobile cancer screening devices market are Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; FUJIFILM Holdings Corporation; Hologic Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Konica Minolta Inc.; Samsung Medison Co. Ltd.; SonoSite (Fujifilm); Carestream Health Inc.; Neusoft Medical Systems; Esaote S.p.A.; Samsung NeuroLogica; Butterfly Network Inc.; Trivitron Healthcare Pvt. Ltd.; Planmed Oy; BPL Medical Technologies Private Limited; UE LifeSciences Inc.; Niramai Health Analytix Private Limited; Forward Science LLC
Access The Complete Mobile Cancer Screening Devices Market Report:
Mobile Cancer Screening Devices Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the mobile cancer screening devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile cancer screening devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.